Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joerg Herrmann

Showing results (31-40 of 269) with videos related to

Pageof 27
Sort By:
American Journal of Cardiovascular Disease|June 12, 2015
Dysfunction of the ubiquitin-proteasome system in atherosclerotic cardiovascular diseaseFeilong Wang, Amir Lerman, Joerg Herrmann
European Heart Journal|August 26, 2010
Simply say yes to NO? Nitric oxide (NO) sensor-based assessment of coronary endothelial functionJoerg Herrmann, Lilach Lerman, Amir Lerman
Current Oncology Reports|September 12, 2018
Building a Cardio-Onco-Hematology ProgramJoerg Herrmann, Charles Loprinzi, Kathryn Ruddy
Trends in Cardiovascular Medicine|July 28, 2016
Use of fractional flow reserve in patients with coronary artery disease: The right choice for the right outcomeJae Yoon Park, Amir Lerman, Joerg Herrmann
Cardiovascular Research|October 10, 2009
On to the road to degradation: atherosclerosis and the proteasomeJoerg Herrmann, Lilach O Lerman, Amir Lerman
JACC. Cardiooncology|April 17, 2025
Outcomes and Predictors of Severity of Immunotherapy-Related MyocarditisDame Idossa, Joerg Herrmann, Kathryn J Ruddy
Nature Reviews. Clinical Oncology|October 14, 2015
Systems biology approaches to adverse drug effects: the example of cardio-oncologySherry-Ann Brown, Nicole Sandhu, Joerg Herrmann
Circulation Research|May 15, 2007
Ubiquitin and ubiquitin-like proteins in protein regulationJoerg Herrmann, Lilach O Lerman, Amir Lerman
European Heart Journal|August 24, 2012
Coronary microvascular dysfunction in the clinical setting: from mystery to realityJoerg Herrmann, Juan Carlos Kaski, Amir Lerman
Progress in Cardiovascular Diseases|August 2, 2014
Cardio-oncology: role of echocardiographyHector R Villarraga, Joerg Herrmann, Vuyisile T Nkomo
Pageof 27

Showing results (31-40 of 269) with videos related to

Sort By:
Pageof 27
American Journal of Cardiovascular Disease|June 12, 2015
Dysfunction of the ubiquitin-proteasome system in atherosclerotic cardiovascular diseaseFeilong Wang, Amir Lerman, Joerg Herrmann
European Heart Journal|August 26, 2010
Simply say yes to NO? Nitric oxide (NO) sensor-based assessment of coronary endothelial functionJoerg Herrmann, Lilach Lerman, Amir Lerman
Current Oncology Reports|September 12, 2018
Building a Cardio-Onco-Hematology ProgramJoerg Herrmann, Charles Loprinzi, Kathryn Ruddy
Trends in Cardiovascular Medicine|July 28, 2016
Use of fractional flow reserve in patients with coronary artery disease: The right choice for the right outcomeJae Yoon Park, Amir Lerman, Joerg Herrmann
Cardiovascular Research|October 10, 2009
On to the road to degradation: atherosclerosis and the proteasomeJoerg Herrmann, Lilach O Lerman, Amir Lerman
JACC. Cardiooncology|April 17, 2025
Outcomes and Predictors of Severity of Immunotherapy-Related MyocarditisDame Idossa, Joerg Herrmann, Kathryn J Ruddy
Nature Reviews. Clinical Oncology|October 14, 2015
Systems biology approaches to adverse drug effects: the example of cardio-oncologySherry-Ann Brown, Nicole Sandhu, Joerg Herrmann
Circulation Research|May 15, 2007
Ubiquitin and ubiquitin-like proteins in protein regulationJoerg Herrmann, Lilach O Lerman, Amir Lerman
European Heart Journal|August 24, 2012
Coronary microvascular dysfunction in the clinical setting: from mystery to realityJoerg Herrmann, Juan Carlos Kaski, Amir Lerman
Progress in Cardiovascular Diseases|August 2, 2014
Cardio-oncology: role of echocardiographyHector R Villarraga, Joerg Herrmann, Vuyisile T Nkomo
Pageof 27